Active Iris in Retinopathy of Prematurity andRegression Following Intravitreal RanibizumabInjection

摘要

Classic active iris vasculature in retinopathyof prematurity is shown, as well as regressionwithin 24 hours of off-label ranibizumab injection(0.25 mg) in both eyes.